Article Figures & Data
Figures
- FIGURE 1.
(A–E) Posttherapy 131I scan (anterior images) demonstrating iodine uptake in pelvic lesion after first RAI cycle (A), second cycle (B), third cycle (C), fourth cycle (D), and fifth cycle (E), showing progressive response. (F and G) Posterior images demonstrating iodine uptake in lung nodules and pelvic lesions after first RAI cycle (F) and after fifth cycle (G).
- FIGURE 2.
Maximum-intensity projection image of 18F-FDG PET/CT scan showing very low-grade 18F-FDG uptake (arrows) in pelvic mass (A), right internal iliac deposit (B) and lung nodules (C). (A–C) Left-side images are fused PET/CT axial images, and right-side images are CT axial images.
Tables
- TABLE 1.
Thyroglobulin and Thyroid-Stimulating Hormone Values over Course of Treatment from Baseline to Last Follow-up
Time Thyroglobulin (ng/mL) Thyroid- stimulating hormone (μIU/mL) Thyroid-stimulating hormone stimulated Baseline (before first RAI cycle) >300 1.67 6 mo after first RAI cycle >300 13.98 1 y after second RAI cycle 300 58 1 y after third RAI cycle 288 52 1 y after fourth RAI cycle/ before fifth RAI cycle 269 46.6 Thyroid-stimulating hormone suppressed Recent follow-up (6 mo after fifth RAI cycle) 75 0.008
